Mayne Pharma International Pty Ltd. v. Merck & Co., Inc., et al
Mayne Pharma International Pty Ltd. |
Merck & Co., Inc., Merck Sharp & Dohme Corp. and N.V. Organon |
1:2015cv00438 |
May 29, 2015 |
US District Court for the District of Delaware |
Wilmington Office |
New Castle |
Christopher J. Burke |
Leonard P. Stark |
Patent |
35 U.S.C. ยง 271 |
Plaintiff |
Available Case Documents
The following documents for this case are available for you to view or download:
Document Text |
---|
Filing 116 MEMORANDUM OPINION re claim construction. Signed by Judge Leonard P. Stark on 12/27/16. (etg) |
Filing 18 REPORT AND RECOMMENDATIONS recommending GRANTING-IN-PART without prejudice D.I. 10 MOTION to Dismiss for Failure to State a Claim filed by Merck Sharp & Dohme Corp., Merck & Co., Inc., N.V. Organon. Please note that when filing Ob jections pursuant to Federal Rule of Civil Procedure 72(b)(2), briefing consists solely of the Objections (no longer than ten (10) pages) and the Response to the Objections (no longer than ten (10) pages). No further briefing shall be permitted with respect to objections without leave of the Court. Objections to R&R due by 12/21/2015. Signed by Judge Christopher J. Burke on 12/3/2015. (mlc) |
Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Access this case on the Delaware District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.